These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35800138)

  • 21. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
    Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P
    Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure.
    Smart NA; Meyer T; Butterfield JA; Faddy SC; Passino C; Malfatto G; Jonsdottir S; Sarullo F; Wisloff U; Vigorito C; Giallauria F
    Eur J Prev Cardiol; 2012 Jun; 19(3):428-35. PubMed ID: 21543459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis.
    Song JL; Fan B; Qiu LQ; Li Q; Chen GY
    BMC Anesthesiol; 2024 Aug; 24(1):276. PubMed ID: 39112946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between brain natriuretic peptides and recurrence of atrial fibrillation after successful direct current cardioversion: a meta-analysis.
    Zografos T; Maniotis C; Katsivas A; Katritsis D
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1530-7. PubMed ID: 25113607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
    Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
    Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
    Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
    Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of exercise training on postprandial glycemia and insulinemia in adults with overweight or obesity and with cardiometabolic disorders: A systematic review and meta-analysis.
    Khalafi M; Symonds ME; Ghasemi F; Rosenkranz SK; Rohani H; Sakhaei MH
    Diabetes Res Clin Pract; 2023 Jul; 201():110741. PubMed ID: 37276984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
    Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
    BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis.
    Harrison TG; Shukalek CB; Hemmelgarn BR; Zarnke KB; Ronksley PE; Iragorri N; Graham MM; James MT
    Am J Kidney Dis; 2020 Aug; 76(2):233-247. PubMed ID: 32387090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme.
    Sweeney C; Pharithi RB; Kerr B; Ryan C; Ryan F; Collins L; Halley C; Barrett M; Watson CJ; McDonald K; Ledwidge M
    ESC Heart Fail; 2021 Dec; 8(6):5081-5091. PubMed ID: 34586748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of Exercise Interventions on Inflammatory Markers and Vascular Adhesion Molecules in Patients With Heart Failure: A Meta-analysis of RCTs.
    Malandish A; Karimi A; Naderi M; Ghadamyari N; Gulati M
    CJC Open; 2023 Jun; 5(6):429-453. PubMed ID: 37397615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
    Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.
    Santaguida PL; Don-Wauchope AC; Oremus M; McKelvie R; Ali U; Hill SA; Balion C; Booth RA; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):453-70. PubMed ID: 25062653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.